K

Avego Bioscience Capital logo

Avego Bioscience Capital

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Series C

PBS Biotech logo
PBS Biotech

Single-use bioreactors • Bioprocess development

BroadOak Capital Partners logo
Avego Management logo

PBS Biotech develops and enhances single-use bioreactor systems and bioprocess development services to improve the production of therapeutic cells for regenerative medicines.

Equity
$17M
01/06/2025
Article
TRexBio logo
TRexBio

Biotechnology • Inflammatory Diseases

Delos Capital logo
Avego BioScience Capital logo
SV Health Investors logo
Pfizer Ventures logo

TRexBio is a biotechnology company developing novel therapies for inflammatory diseases using their Deep Biology platform to focus on immune homeostasis.

Series B
$84M
11/13/2024
Article
Alentis Therapeutics logo
Alentis Therapeutics

Biotech • Clinical-stage

Jeito Capital logo
Novo Holdings logo
OrbiMed logo
RA Capital Management logo

Alentis Therapeutics is a biotech company developing antibody-drug conjugates for treating Claudin-1 positive tumors and organ fibrosis.

Series D
$181.4M
11/12/2024
Article
Evommune logo
Evommune

Biotechnology • Clinical Development

RA Capital Management logo
Verition Fund Management logo
Symbiosis logo
RTW Investments logo

Evommune, Inc. is a biotechnology company focused on developing treatments for chronic inflammatory diseases.

Series C
$115M
10/31/2024
Article